Pricing Log in Create free account

Heron Therapeutics, Inc. (HRTX) vs Nutriband Inc. (NTRB)

Heron Therapeutics, Inc. and Nutriband Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and Nutriband Inc. are of similar size ($76.2M and $71.5M). Heron Therapeutics, Inc. grew revenue faster over the last twelve months: 0.99% against −37.3%. Heron Therapeutics, Inc. has the higher net margin (−22.5% vs −430.4%) and the higher return on invested capital (−6.35% vs −227.9%). Across the 18 metrics below, Heron Therapeutics, Inc. leads on 13 and Nutriband Inc. on 5.

Valuation

Metric HRTX NTRB Biotechnology median
P/E n/m n/m 8.50
P/S 0.45 46.74 9.71
P/B 11.70 14.20 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.11 44.68 9.21
Earnings yield (52.78%) (9.21%) (33.15%)
Free cash flow yield (17.64%) (4.81%) (25.50%)

Profitability

Metric HRTX NTRB Biotechnology median
Gross margin 70.07% 33.14% 65.16%
Operating margin (7.19%) (435.57%) 0.00%
Net margin (22.52%) (430.43%) 0.00%
Free cash flow margin (8.00%) (224.54%) 0.00%
Return on equity 318.21% (100.79%) (56.36%)
Return on assets (14.06%) (84.56%) (48.04%)
Return on invested capital (6.35%) (227.92%) 0.00%

Growth

Metric HRTX NTRB Biotechnology median
Revenue growth (TTM) 0.99% (37.25%) 6.02%
EPS growth (last fiscal year) (33.33%) (160.61%) 30.26%
Revenue growth, 5-year CAGR 11.81% 16.63% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRTX NTRB Biotechnology median
Debt to equity 20.65 0.00 0.00
Current ratio 2.49 4.21 4.72
Net debt to EBITDA (643.88) 0.56 0.96

Dividend

Metric HRTX NTRB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HRTX NTRB Biotechnology median
Market cap 71.48m 76.21m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack